Masa Aki Shibata

Summary

Publications

  1. ncbi Mammary cancer gene therapy targeting lymphangiogenesis: VEGF-C siRNA and soluble VEGF receptor-2, a splicing variant
    Masa Aki Shibata
    Laboratory of Anatomy and Histopathology, Faculty of Health Science, Osaka Health Science University, 1 9 27 Temma, Osaka 530 0043, Japan
    Med Mol Morphol 45:179-84. 2012
  2. ncbi α-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation
    Masa Aki Shibata
    Laboratory of Anatomy and Histopathology, Faculty of Health Science, Osaka Health Science University, Osaka, Japan
    BMC Med 9:69. 2011
  3. ncbi Electrogene transfer of an Epstein-Barr virus-based plasmid replicon vector containing the diphtheria toxin A gene suppresses mammary carcinoma growth in SCID mice
    Masa Aki Shibata
    Department of Anatomy and Biology, Osaka Medical College, Takatsuki, Osaka, Japan
    Cancer Sci 96:434-40. 2005
  4. ncbi Alterations in cell cycle and induction of apoptotic cell death in breast cancer cells treated with α-mangostin extracted from mangosteen pericarp
    Hitomi Kurose
    Division of Life Sciences, Department of Anatomy and Cell Biology, Osaka Medical College, Takatsuki, Osaka, Japan
    J Biomed Biotechnol 2012:672428. 2012
  5. ncbi Mechanism of inflammation in murine eosinophilic myocarditis produced by adoptive transfer with ovalbumin challenge
    Masao Hirasawa
    Department of Anatomy and Biology, Osaka Medical College, Osaka, Japan
    Int Arch Allergy Immunol 142:28-39. 2007
  6. ncbi Development of a 2',4'-BNA/LNA-based siRNA for Dyslipidemia and Assessment of the Effects of Its Chemical Modifications In Vivo
    Shunsuke Wada
    1 Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan 2 Graduate School of Chemical Sciences and Technology, Tokyo University of Science, Shinjuku ku, Tokyo, Japan
    Mol Ther Nucleic Acids 1:e45. 2012
  7. ncbi Easy stable transfection of a human cancer cell line by electrogene transfer with an Epstein-Barr virus-based plasmid vector
    Masa Aki Shibata
    Department of Anatomy and Cell Biology, Division of Basic Medicine I and High Tech Research Center, Osaka Medical College, 2 7, Daigaku machi, Takatsuki, Osaka, 569 8686, Japan
    Med Mol Morphol 40:103-7. 2007

Collaborators

Detail Information

Publications7

  1. ncbi Mammary cancer gene therapy targeting lymphangiogenesis: VEGF-C siRNA and soluble VEGF receptor-2, a splicing variant
    Masa Aki Shibata
    Laboratory of Anatomy and Histopathology, Faculty of Health Science, Osaka Health Science University, 1 9 27 Temma, Osaka 530 0043, Japan
    Med Mol Morphol 45:179-84. 2012
    ..Thus, therapeutic strategies targeting lymphangiogenesis may have great clinical significance for the treatment of metastatic human breast cancer...
  2. ncbi α-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation
    Masa Aki Shibata
    Laboratory of Anatomy and Histopathology, Faculty of Health Science, Osaka Health Science University, Osaka, Japan
    BMC Med 9:69. 2011
    ....
  3. ncbi Electrogene transfer of an Epstein-Barr virus-based plasmid replicon vector containing the diphtheria toxin A gene suppresses mammary carcinoma growth in SCID mice
    Masa Aki Shibata
    Department of Anatomy and Biology, Osaka Medical College, Takatsuki, Osaka, Japan
    Cancer Sci 96:434-40. 2005
    ....
  4. ncbi Alterations in cell cycle and induction of apoptotic cell death in breast cancer cells treated with α-mangostin extracted from mangosteen pericarp
    Hitomi Kurose
    Division of Life Sciences, Department of Anatomy and Cell Biology, Osaka Medical College, Takatsuki, Osaka, Japan
    J Biomed Biotechnol 2012:672428. 2012
    ..In conclusion, α-mangostin may be useful as a therapeutic agent for breast cancer carrying a p53 mutation and having HER2- and hormone receptor-negative subtypes...
  5. ncbi Mechanism of inflammation in murine eosinophilic myocarditis produced by adoptive transfer with ovalbumin challenge
    Masao Hirasawa
    Department of Anatomy and Biology, Osaka Medical College, Osaka, Japan
    Int Arch Allergy Immunol 142:28-39. 2007
    ..We investigated the relationships between these cytokines and receptors in the development of inflammation in murine myocarditis produced by adoptive transfer, with reference to eosinophil infiltration and signal transduction...
  6. ncbi Development of a 2',4'-BNA/LNA-based siRNA for Dyslipidemia and Assessment of the Effects of Its Chemical Modifications In Vivo
    Shunsuke Wada
    1 Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan 2 Graduate School of Chemical Sciences and Technology, Tokyo University of Science, Shinjuku ku, Tokyo, Japan
    Mol Ther Nucleic Acids 1:e45. 2012
    ..Molecular Therapy - Nucleic Acids (2012) 1, e45; doi:10.1038/mtna.2012.32; published online 18 September 2012...
  7. ncbi Easy stable transfection of a human cancer cell line by electrogene transfer with an Epstein-Barr virus-based plasmid vector
    Masa Aki Shibata
    Department of Anatomy and Cell Biology, Division of Basic Medicine I and High Tech Research Center, Osaka Medical College, 2 7, Daigaku machi, Takatsuki, Osaka, 569 8686, Japan
    Med Mol Morphol 40:103-7. 2007
    ....